Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma ; volume:18 ; number:1 ; day:26 ; month:10 ; year:2018 ; pages:1-8 ; date:12.2018
BMC cancer ; 18, Heft 1 (26.10.2018), 1-8, 12.2018
- Creator
-
Park, Jongmoo
Jung, Jinhong
Kim, Daegeun
Jung, In-Hye
Park, Jin-hong
Kim, Jong Hoon
Lee, Sang-wook
Yoon, Sang Min
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4953-x
- URN
-
urn:nbn:de:101:1-2018121622592180912882
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Jongmoo
- Jung, Jinhong
- Kim, Daegeun
- Jung, In-Hye
- Park, Jin-hong
- Kim, Jong Hoon
- Lee, Sang-wook
- Yoon, Sang Min
- SpringerLink (Online service)
Other Objects (12)
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review